细菌细胞外囊泡在全身性疾病中的作用
Yanzhen Wang1, Xinghong Luo1, Xiaozhen Xiang2
1Department of Endodontics, Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, Guangdong, China.
Frontiers in microbiology
|October 16, 2023
概括
细菌细胞外囊泡 (BEVs) 对于微生物群与宿主通信至关重要,提供影响宿主信号和疾病的分子. 这些囊泡在全身性疾病的发病过程中起着重要作用.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 微生物群与宿主之间的相互作用对健康至关重要.
- 这些相互作用并不总是需要直接的细胞接触.
- 细菌细胞外囊泡 (BEVs) 正在成为跨王国通信的关键媒介.
研究的目的:
- 审查当前对细菌细胞外囊泡 (BEVs) 的理解.
- 突出BEV在宿主相互作用中的作用.
- 强调BEVs在全身性疾病的发病过程中的参与.
主要方法:
- 对细菌细胞外囊泡研究的文献综述.
- 对BEVs调节主机信号通路的机制的分析.
- 在感染 (致病性和益生菌性) 期间检查BEV生产.
主要成果:
- BEVs提供效应分子,影响宿主信号,并促进宿主-微生物交叉通话.
- 在感染期间,在各种宿主组织中观察到BEV的产生.
- BEVs具有驱动和抑制疾病致病的潜力.
结论:
- 细菌细胞外囊泡是微生物群与宿主通信的关键媒介.
- 在系统性疾病的发病过程中,BEVs发挥着重要作用.
- 对BEV进行进一步的研究是有必要的,以了解它们的治疗潜力.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Bacterial Translocation and Protein Secretion
25
Bacterial protein secretion involves translocation systems to ensure proteins reach their designated locations, including the plasma membrane, periplasm, outer membrane, or the external environment. These translocation systems are vital for bacterial physiology, supporting processes like membrane assembly, enzymatic activity in the periplasm, and interactions with the external environment. The division of labor between Sec and Tat pathways ensures efficiency in handling proteins with diverse...
25
Gram-negative Bacterial Protein Secretion Systems
30
Gram-negative bacteria utilize sophisticated protein secretion systems to transport proteins across their double-membrane envelope into the extracellular environment or host cells. Based on their mechanism of action, these systems are classified into one-step and two-step pathways.One-Step Secretion Systems (Types I, III, IV, and VI)One-step secretion systems bypass the periplasm entirely, forming a continuous channel that spans both the inner and outer membranes:Type I Secretion System (T1SS):...
30
Intracellular Movement of Viruses and Bacteria
2.9K
Intracellular bacteria and viruses often comprise a group of highly infectious pathogens that can cause several diseases. Bacterial pathogens include those belonging to the genus Rickettsia responsible for conditions such as rocky mountain spotted fever and the Mediterranean spotted fever; Chlamydia, a genus responsible for a sexually transmitted disease; Coxiella burnetii, an agent responsible for Q fever. Viral pathogens include vaccinia—a poxvirus, and herpes simplex virus—a...
2.9K
Intralumenal Vesicles and Multivesicular Bodies
3.5K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.5K
Microorganisms in Medicine and Therapeutics
36
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
36


